title: Interferon gamma +874 T/A polymorphism increases the risk of cervical cancer: evidence from a meta-analysis.
abstract: Data from previous studies about the association between interferon gamma (IFN-γ) +874 T/A (rs2430561) polymorphism and cervical cancer risk offer controversial results. To obtain a more dependable conclusion, this meta-analysis was performed. We selected eight articles including nine case-control studies with 1,116 cases and 1,290 controls, odds ratios (OR) with 95 % confidence intervals (CI) were used to assess the strength of the association. Subgroup analysis was carried out by ethnicity, source of controls, genotyping methods, and score of quality assessment. Our meta-analysis indicated that the IFN-γ (+874 T/A) polymorphism significantly increased the risk of cervical cancer in the codominant model (TA vs. TT: OR = 1.471, 95 % CI = 1.137-1.903, P = 0.003, I (2) % = 0.0, P Q  = 0.785) and the dominant model (TA + AA vs. TT: OR = 1.399, 95 % CI = 1.097-1.784, P = 0.007, I (2) % = 0.0, P Q  = 0.486) in the overall population. Stratified analysis by ethnicity indicated a significantly increased risk of cervical cancer in Asians in the codominant model (TA vs. TT: OR = 1.494, 95 % CI = 1.069-2.087, P = 0.019, I (2) % = 0.0, P Q  = 0.440) and the dominant model (OR = 1.455, 95 % CI = 1.062-1.993, P = 0.019, I (2) % = 42.9, P Q  = 0.154). Thus, the IFN-γ (+874 T/A) polymorphism is likely to increase the risk of cervical cancer. Because of the limited studies and sample sizes included in our meta-analysis, further well-designed and large-scale studies are demanded to confirm our results.
authors: Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, 530021, Guangxi, People's Republic of China.
authors: Yifan
authors: Y
authors: Sun
authors: Yu
authors: Y
authors: Lu
authors: Qiliu
authors: Q
authors: Pen
authors: Taijie
authors: T
authors: Li
authors: Li
authors: L
authors: Xie
authors: Yan
authors: Y
authors: Deng
authors: Aiping
authors: A
authors: Qin
mesh_terms: D044466:Asian People / Q000235:genetics; D005260:Female; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D007371:Interferon-gamma / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000473:pathology
chemical_list: D007371:Interferon-gamma
references: Eur J Pharmacol. 2009 Dec 25;625(1-3):122-30
references: 19836373
references: Gynecol Oncol. 2010 Mar;116(3):544-8
references: 19959217
references: Stat Med. 2002 Jun 15;21(11):1539-58
references: 12111919
references: J Neural Transm (Vienna). 2011 Feb;118(2):271-4
references: 21161299
references: Hum Immunol. 2004 Dec;65(12):1413-9
references: 15603866
references: Cancer Lett. 2003 Jan 28;189(2):183-8
references: 12490311
references: Mol Biol Rep. 2014 Jan;41(1):373-85
references: 24271138
references: BJOG. 2009 Nov;116(12):1671-7
references: 19681846
references: BMJ. 2001 Jul 14;323(7304):101-5
references: 11451790
references: J Interferon Cytokine Res. 2009 May;29(5):285-8
references: 19232001
references: Clin Cancer Res. 2013 Apr 1;19(7):1858-72
references: 23444227
references: Exp Oncol. 2008 Sep;30(3):224-9
references: 18806746
references: Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):330-3
references: 21719187
references: BMJ. 2003 Sep 6;327(7414):557-60
references: 12958120
references: Mol Biol Rep. 2011 Oct;38(7):4461-7
references: 21127993
references: Int J Cancer. 2002 Jan 1;97(1):72-81
references: 11774246
references: J Exp Med. 1994 Apr 1;179(4):1367-71
references: 7908325
references: Infect Agent Cancer. 2010 Oct 20;5:19
references: 20961432
references: Eur J Hum Genet. 2006 Apr;14(4):488-96
references: 16493441
references: Eur J Immunogenet. 2002 Jun;29(3):237-40
references: 12047360
references: Am J Epidemiol. 2005 Aug 1;162(3):201-11
references: 15987731
references: Mol Biol Rep. 2012 Jul;39(7):7627-34
references: 22327783
references: Eur J Obstet Gynecol Reprod Biol. 2008 Oct;140(2):241-4
references: 18502564
references: Int J Gynecol Cancer. 2004 Jan-Feb;14(1):118-25
references: 14764039
references: Semin Surg Oncol. 1999 Apr-May;16(3):203-11
references: 10225296
references: Annu Rev Biochem. 1998;67:227-64
references: 9759489
references: Surgery. 2009 Nov;146(5):931-8
references: 19733878
references: Future Oncol. 2005 Jun;1(3):323-30
references: 16556006
references: Hepat Mon. 2014 Jan 23;14(1):e14476
references: 24497880
references: Hum Immunol. 2000 Sep;61(9):863-6
references: 11053629
references: J Carcinog. 2003 May 16;2(1):3
references: 12809559